Diversified growth masks NBFC stumble
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks ā the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit consolidated revenue target (ā¹515.1 Cr vs actual); missed NBFC AUM guidance (8.3% decline vs 15ā20% expected); beat insurance guidance (44% vs 15% expected).
Cautiously Optimistic
next 1ā2 quarters
Optimistic
multi-year
Broking and insurance revenue momentum is real (21.2% and 44.4% YoY), but the group is burning shareholder value in transition: NBFC AUM fell 8.3% QoQ despite 15ā20% prior guidance, and insurance EBIT margin collapsed to 1% as the business scales. Management's 20% CAGR aspiration hangs on a) insurance sustaining that 44% growth (structural, plausible) and b) NBFC stabilizing (delayed by product repositioning, needs 1ā2 years per CFO). Near-term risk is uneven: broking solid, insurance revenue surges but profits lag, NBFC needs a rebound. Credibility is mixed; missed NBFC but hit overall revenue. Neutral stance reflects guidance miss on the NBFC anchor, offset by insurance upside.
ā¹515.1 Cr
Revenue Ā· +21.2% YoYā¹36.7 Cr
Reported PAT Ā· +22.7% YoYFlat
Margins Ā· vs guidance: MixedDid the claims hold up?
NBFC AUM recovery on track for FY27
MISSNBFC AUM declined 8.3% QoQ to ā¹1,025 Cr from ā¹1,118 Cr; guidance was 15ā20% growth annually
Insurance segment momentum strong, 15% growth expected
OVERSTATEDInsurance revenue grew 44.4% YoY to ā¹167.3 Cr; vastly exceeded prior guidance
Broking revenue steady despite derivatives headwind
METBroking revenue +15.1% YoY to ā¹316.3 Cr; cash market brokerage rose to 55% from 45%
Insurance EBIT compression temporary due to distribution investment
METInsurance EBIT only ā¹1.6 Cr despite ā¹167.3 Cr revenue; margin ~1%, vs prior quarter likely higher
Overall PAT growth 22% reflects consistent execution
METPAT grew 22.7% YoY, aligned with revenue growth 21.2%; NBFC drag offset by broking/insurance scale
Earnings quality
What changed since the last call
NBFC guidance downgrade (product repositioning)
DowngradePrior: 15ā20% AUM growth annually. Actual Q1: -8.3% QoQ. Closed LAP (ā¹50 Cr decline) & unsecured (ā¹40 Cr decline) to shift to secured retail. FY27 closing target ā¹1,250ā1,300 Cr (7ā27% recovery over 3Q, lower than prior multi-year target).
Insurance growth inflection (outpacing guidance)
UpgradePrior: 15% growth expected. Actual Q1: +44.4% YoY. Driven by non-life surge (90% of premium). But EBIT compressed due to distribution & tech capex for reinsurance opportunity; margin recovery timing now key.
Broking derivatives to cash market mix shift (structural)
NeutralRegulatory headwind on derivatives (prior year measure impact), management notes market participants shifting to delivery-based trading. Broking MTF/T+5 book rose ā¹140 Cr (ā¹760 to ā¹900 Cr); cash brokerage % up 45 to 55%.
The Q&A
Q&A was direct and low-pressure. Analysts probed NBFC miss, insurance EBIT, and 5-year strategy. Management acknowledged AUM decline, explained product mix rationale (shift to secured, higher yields), and stood by 20% CAGR aspiration with 1ā2 year caveat on NBFC. Tone: not defensive, but cautious.
NBFC AUM guidance miss ā Manish Bhandari, Quantum Shares
AnsweredAUM ā¹1,025 Cr (Q1) vs ā¹1,118 Cr (Q4), slight decline. Focused on secured retail (Micro LAP, Gold Loan). Discontinued LAP (-ā¹50 Cr) and tightened unsecured business loans (-ā¹40 Cr) as precaution. FY27 closing target ā¹1,250ā1,300 Cr. Q1 slow; focus products picking up. 5-year CAGR aim 20ā25%, but expect 1ā2 year ramp before that materialization.
Insurance EBIT compression vs revenue growth ā Aditya Dhar, GAAB Investments
AnsweredPrimarily investing in manpower; corporate & life insurance headcount costs rising. Expect operating leverage in future quarters as results flow. Also investing in distribution & tech infrastructure for reinsurance license opportunity.
Broking revenue drivers Q1 amid derivatives slowdown ā Aditya Dhar, GAAB Investments
AnsweredNifty/Sensex +6ā7%; DII inflows >ā¹2 lakh Cr (FPI outflow ~ā¹1.5 lakh Cr). Geopolitical crisis settling (crude down). Cash market business increased, MTF/T+5 up ā¹140 Cr, cash brokerage % up 45ā55%. Shift from derivatives to cash; bullish on Indian economy.
5-year company strategy & revenue targets ā Yash Choudhury, Investor
PartialIndia GDP 7% CAGR. Capital markets beneficiary. SMC leading player, 4,000+ employees, 400+ city presence, 200 branches, all stock exchange memberships. SMC CAGR 20% YoY, will grow faster. FY27 revenue ~ā¹2,000 Cr; if 20% CAGR, ā¹6,000ā8,000 Cr in 5 years. Current PAT ā¹103 Cr (FY26); expecting ā¹170 Cr.
NBFC NIM outlook & interest rate sensitivity ā Aditya Dhar, Cabin Investments
AnsweredQ1: reduced weighted cost of funds by ~25 bps. Annual reset on existing borrowings at lower rates; new borrowings also lower. Cost reduction 25 bps. NIM focus: increasing blended yield of AUM via high-yielding retail products. Expect NIM to grow gradually over coming years.
Stoxkart platform performance & scaling ā Aditya Dhar, Cabin Investments
AnsweredLast 5Q strong. Quadrupled revenue YoY: Q1 2025 base vs Q1 2026 = ā¹20 Cr (reported as Q1 2026 contributed ā¹20 Cr). Opened ~26,000 subscription clients (Smart Trader Plan: upfront subscription for software + trading). Model new to industry, mimics SaaS. Very hopeful sizable business going forward, major contribution to SMC revenues.
AI & digital roadmap ā Manish Bhandari, Quantum Shares
AnsweredBuilt AI enablement base past 6 months. Launched AI Chatbot (proprietary low-language model, own AI agent, cost-efficient). Launched AI Algo platform (aggressive). Integrating AI in mobile app: AI-generated insights via proprietary research, script analysis, trend analysis. Testing; launch very soon.
Guidance
Consolidated FY27 revenue on track; no specific FY27 target disclosed
MediumChairman expects ā¹2,000 Cr+ FY27 base (implies low incremental from Q1 run rate ā¹2.06 Cr annualized); 20% CAGR over 5 years would reach ā¹6,000ā8,000 Cr by FY32
Insurance revenue: prior 15% growth; Q1 achieved 44.4%
HighStructural tailwind (insurance penetration, regulatory tailwind, distribution network expansion). Reinsurance license deployment expected H2 FY27+
NBFC AUM closing FY27: ā¹1,250ā1,300 Cr
MediumImplies 7ā27% recovery from Q1 ā¹1,025 Cr over 3 quarters. Prior guidance was 15ā20% annualized growth; now throttled due to product repositioning
Insurance margin recovery deferred; expect operating leverage future quarters
MediumQ1 EBIT ā¹1.6 Cr (1% margin) vs prior likely 5ā8%. Investments in distribution/tech for reinsurance opportunity; timing of inflection undefined
NBFC NIM expected to grow gradually over coming years via secured product mix shift
HighCost of funds -25 bps Q1. Blended yield increasing as book shifts to high-yielding retail (Micro LAP, Gold Loan). Secured products have higher spreads
Broking EBIT margin stable; EBIT growth tracking revenue on cost discipline
HighQ1 EBIT ā¹74.3 Cr on ā¹316.3 Cr revenue = 23.5% margin; +17.6% YoY growth shows operating leverage from fixed-cost absorption
Risks the call surfaced
NBFC AUM decline & recovery risk
HighNBFC AUM ā¹1,025 Cr (Q1) vs ā¹1,118 Cr (Q4 FY26) = -8.3% QoQ. Prior guidance 15ā20% annual growth. Discontinued LAP (-ā¹50 Cr) & unsecured loans (-ā¹40 Cr) explain ~ā¹90 Cr, leaving unexplained softness. If FY27 closing target (ā¹1,250ā1,300 Cr) misses, signals demand weakness beyond product mix shift.
Insurance EBIT margin compression
MediumInsurance segment revenue ā¹167.3 Cr (+44.4% YoY) but EBIT only ā¹1.6 Cr (~1% margin). Prior quarter likely 5ā8% EBIT margin. Management attributes to distribution headcount & tech capex for reinsurance license opportunity. Risk: if margin recovery delayed or insufficient, insurance business becomes a growth-without-profit drag despite strong premium growth.
Derivatives regulation headwind & market volatility
MediumBroking revenue +15.1% YoY driven by cash market shift (45ā55% brokerage %, MTF book +ā¹140 Cr). But derivatives segment under regulatory pressure (regulatory measures over past year cited by management). Risk: if derivatives revenue continues to erode faster than cash market compensates, broking growth could decelerate.
Execution risk on tech/AI roadmap
LowManagement committed to AI chatbot, AI Algo platform, mobile app AI insights (script analysis, trend analysis). All flagged as 'testing' or 'launching very soon.' Risk: if rollout delayed or features underperform vs. peer offerings, competitive differentiation and cost efficiency claims may not materialize.
Management
Score 7/10. Direct & candid on misses (NBFC AUM decline acknowledged, explained by product repositioning). Insurance EBIT compression contextualized as temporary investment phase. No deflection or jargon; specific numbers on AUM, revenue, EBIT. Transparency moderate: withheld some specifics on AI rollout timeline, reinsurance license deployment. Mixed track record. Hit consolidated revenue (ā¹515.1 Cr). Missed NBFC guidance (8.3% AUM decline vs 15ā20% prior). Beat insurance (44.4% vs 15%). Broking on track. Stoxkart 4x YoY revenue growth is tangible execution win. NBFC repositioning under way but timing of CAGR recovery uncertain.
1 Ā· Q2 FY27 (Sept 2026)
Broking revenue trajectory & derivative vs cash mix normalization post-geopolitical calm
2 Ā· FY27 full year
NBFC AUM recovery to ā¹1,250ā1,300 Cr target; insurance margin inflection post-investments
3 Ā· H2 FY27
Insurance reinsurance license monetization & composite broker license deployment
Neutral stance reflects guidance miss on the NBFC anchor, offset by insurance upside.
Informational and educational content only. Not investment advice.